Results 241 to 250 of about 74,225 (263)

Gut microbiota reshapes the TNBC immune microenvironment: Emerging immunotherapeutic strategies

Pharmacological Research
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited treatment options and poor prognosis. The gut microbiota, a diverse community of microorganisms in the gastrointestinal tract, plays a crucial role in regulating ...
Xuexin Li, Yikai Zhang, Xueqiang Peng
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options

Pharmacology & Therapeutics, 2022
Stan Lipkowitz
exaly  

G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression

Cellular and Molecular Life Sciences, 2023
Zhenkun Fu, Chenggang Li, Zhoujun Lin
exaly  

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)

Pharmaceuticals, 2022
Pradeep Kumar Bolla, Dinesh Kumar, Deepa Dehari   +2 more
exaly  

Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes

Cancers, 2022
Melanie Gisela Cornejo Germer, Joseph Arturo Pinto, Jhajaira Araujo   +2 more
exaly  

IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells

Cells, 2020
Jorge Silvio Gutkind, Nijiro Nohata, Marcello Maggiolini   +2 more
exaly  

S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells

International Journal of Molecular Sciences, 2021
Maria Francesca Santolla, Marcello Maggiolini, Marianna Talia   +2 more
exaly